About this episode

The episode discusses the advancements in circulating tumor DNA technology in B-cell lymphomas with experts Dr. Ash Alizadeh and Dr. David Russler-Germain.

In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington University in St. Louis, returns as a familiar voice to the podcast audience. Joining him is Dr. Ash Alizadeh, the Moghadam Family Professor of Medicine, Oncology, and Hematology at Stanford University and leader of the Cancer Genomics Program at Stanford Cancer Institute. Dr. Alizadeh has been instrumental in advancing our understanding of lymphomagenesis and lymphoma genetics over the past two decades, pioneering multiple ctDNA techniques that are revolutionizing cancer care. Together, they discuss the transformative potential of ctDNA technology in B-cell lymphomas, particularly DLBCL, covering everything from the technical evolution of biomarker detection to groundbreaking clinical data that may reshape how we monitor and treat these aggressive cancers. Key Discussion Topics 1. Genetic Heterogeneity in B-Cell Lymphomas Complex genetic landscape of DLBCL Implications for treatment strategies Need for…

People in this episode

Hosts: Rajshekhar Chakraborty, Ashwin Kishtagari, Edward Cliff

Guests: Dr. Ash Alizadeh, Dr. David Russler-Germain

Topics covered

• circulating tumor DNA
• B-cell lymphomas
• DLBCL
• lymphomagenesis
• cancer genetics
• biomarker detection
• personalized treatment

Keywords

• circulating tumor DNA
• DLBCL
• lymphoma
• cancer care
• biomarkers
• genetic heterogeneity
• prognostic information

Mentioned in this episode

Organizations: Siteman Cancer Centre, Stanford University, Stanford Cancer Institute

More episodes of Blood Cancer Talks

• Episode 70. ASH 2025 Myeloid Neoplasm Roundup with Dr. Curtis Lachowiez · February 27, 2026 · 57 min
• Episode 69. ASH 2025 Lymphoma Roundup with Dr. Carla Casulo · January 22, 2026 · 44 min
• Episode 68. ASH 2025 Myeloma Special: MajesTEC-3 and the Bispecific Revolution with Dr. Luciano Costa · January 2, 2026 · 46 min
• Episode 67. Management of CMV in Hematologic Malignancies · November 23, 2025 · 40 min
• Episode 66. International Myeloma Society 2025 Annual Meeting Updates with Dr. Alfred Garfall: The Bispecific Bonanza · October 15, 2025 · 52 min
• Episode 64. Lymphoma Updates from EHA and ICML 2025 with Dr. Adrian Minson · August 20, 2025 · 43 min

Explore listener stats, chart rankings, contacts and more on the Blood Cancer Talks podcast page.